US Patent Issued to Senhwa Biosciences on July 7 for "Combination therapy of tetracyclic quinolone analogs for treating cancer" (California Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,062, issued on July 7, was assigned to Senhwa Biosciences Inc. (New Taipei City, Taiwan).

"Combination therapy of tetracyclic quinolone analogs for treating cancer" was invented by John Soong (Chino, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods, compositions, and combinations for treating cancer via combined use of a compound of formula I or a pharmaceutically acceptable salt, ester, solvate and/or prodrug thereof, wherein A, Q, n, m, R7, R8, V, X1, X2, X3, X4, X5, X6, and X7 are as defined herein, and at least one therapeutically active agents selected from immunotherapeutics, anticancer agents, and an...